Bush RL, Lin PH, Lumsden AB. Management of thrombosed dialysis access: thrombectomy versus thrombolysis. Semin Vasc Surg. 2004;17:32–9. https://doi.org/10.1053/j.semvascsurg.2003.11.005.
Bent CL, Sahni VA, Matson MB. The radiological management of the thrombosed arteriovenous dialysis fistula. Clin Radiol. 2011;66:1–12. https://doi.org/10.1016/j.crad.2010.05.010.
Article PubMed CAS Google Scholar
Regus S, Almasi-Sperling V, Rother U, et al. Comparison between open and pharmacomechanical repair of acutely thrombosed arteriovenous hemodialysis fistulae within a decade. Hemodial Int. 2018;22:445–53. https://doi.org/10.1111/hdi.12660.
Sorita A, Ahmed A, Starr SR, et al. Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis. BMJ. 2014;348:f7393. https://doi.org/10.1136/bmj.f7393.
Article PubMed PubMed Central Google Scholar
Kato K, Otsuka T, Nakai M, et al. Effect of holiday admission for acute aortic dissection on in-hospital mortality in Japan: a nationwide study. PLoS ONE. 2021;16:e0260152. https://doi.org/10.1371/journal.pone.0260152.
Article PubMed PubMed Central CAS Google Scholar
Lunz D, Camboni D, Philipp A, et al. The “Weekend Effect” in adult patients who receive extracorporeal cardiopulmonary resuscitation after in- and out-of-hospital cardiac arrest. Resusc Plus. 2020;4:100044. https://doi.org/10.1016/j.resplu.2020.100044.
Article PubMed PubMed Central Google Scholar
Leatherby RJ, Shan MR, Antoniou GA. Editor’s choice—Systematic review and meta-analysis of the effect of weekend admission on outcomes for ruptured abdominal aortic aneurysms: a call for an equitable seven day vascular service. Eur J Vasc Endovasc Surg. 2021;61:767–78. https://doi.org/10.1016/j.ejvs.2020.12.022.
Regus S, Lang W, Heinz M, et al. Benefits of long versus short thrombolysis times for acutely thrombosed hemodialysis native fistulas. Vasc Endovascular Surg. 2017;51:233–9. https://doi.org/10.1177/1538574417715182.
Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Interv Radiol. 2017;40:1141–6. https://doi.org/10.1007/s00270-017-1703-4.
Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75:S1–164. https://doi.org/10.1053/j.ajkd.2019.12.001.
Schmidli J, Widmer MK, Basile C, et al. Editor’s Choice—Vascular access: 2018 clinical practice guidelines of the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:757–818. https://doi.org/10.1016/j.ejvs.2018.02.001.
Poulain F, Raynaud A, Bourquelot P, et al. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas. Cardiovasc Interv Radiol. 1991;14:98–101. https://doi.org/10.1007/BF02577703.
Sands JJ, Patel S, Plaviak DJ, et al. Pharmacomechanical thrombolysis with urokinase for treatment of thrombosed hemodialysis access grafts. A comparison with surgical thrombectomy. ASAIO J. 1994;40:M886–8. https://doi.org/10.1097/00002480-199407000-00123.
Article PubMed CAS Google Scholar
Haage P, Vorwerk D, Wildberger JE, et al. Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int. 2000;57:1169–75. https://doi.org/10.1046/j.1523-1755.2000.00944.x.
Article PubMed CAS Google Scholar
Vogel PM, Bansal V, Marshall MW. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device. J Vasc Interv Radiol. 2001;12:1157–65. https://doi.org/10.1016/s1051-0443(07)61672-8.
Article PubMed CAS Google Scholar
Sofocleous CT, Hinrichs CR, Weiss SH, et al. Alteplase for hemodialysis access graft thrombolysis. J Vasc Interv Radiol. 2002;13:775–84. https://doi.org/10.1016/s1051-0443(07)61985-x.
Cooper SG. Original report. Pulse-spray thrombolysis of thrombosed hemodialysis grafts with tissue plasminogen activator. AJR Am J Roentgenol. 2003;180:1063–6. https://doi.org/10.2214/ajr.180.4.1801063.
Schon D, Mishler R. Pharmacomechanical thrombolysis of natural vein fistulas: reduced dose of TPA and long-term follow-up. Semin Dial. 2003;16:272–5. https://doi.org/10.1046/j.1525-139x.2003.16052.x.
Vashchenko N, Korzets A, Neiman C, et al. Retrospective comparison of mechanical percutaneous thrombectomy of hemodialysis arteriovenous grafts with the Arrow-Trerotola device and the lyse and wait technique. AJR Am J Roentgenol. 2010;194:1626–9. https://doi.org/10.2214/AJR.09.3095.
Choi SY, Choi BG, Han KH, et al. Efficacy of a modified pharmacomechanical thrombolysis technique for endovascular treatment of thrombosed prosthetic arteriovenous grafts. Korean J Radiol. 2012;13:300–6. https://doi.org/10.3348/kjr.2012.13.3.300.
Article PubMed PubMed Central Google Scholar
Umanath K, Morrison RS, Christopher Wilbeck J, et al. In-center thrombolysis for clotted AV access: a cohort review. Semin Dial. 2013;26:124–9. https://doi.org/10.1111/j.1525-139X.2012.01105.x.
Lee HS, Park PJ. Clinical outcome of percutaneous thrombectomy of dialysis access thrombosis by an interventional nephrologist. Kidney Res Clin Pract. 2014;33:204–9. https://doi.org/10.1016/j.krcp.2014.10.004.
Article PubMed PubMed Central Google Scholar
Nassar GM, Rhee E, Khan AJ, et al. Percutaneous thrombectomy of AVF: immediate success and long-term patency rates. Semin Dial. 2015;28:E15-22. https://doi.org/10.1111/sdi.12336.
Nikam MD, Ritchie J, Jayanti A, et al. Acute arteriovenous access failure: long-term outcomes of endovascular salvage and assessment of co-variates affecting patency. Nephron. 2015;129:241–6. https://doi.org/10.1159/000375500.
Regus S, Lang W, Heinz M, et al. Time-extended local rtPA infiltration for acutely thrombosed hemodialysis fistulas. Hemodial Int. 2018;22:31–6. https://doi.org/10.1111/hdi.12528.
Tan RY, Pang SC, Teh SP, et al. Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access. J Vasc Access. 2019;20:501–6. https://doi.org/10.1177/1129729818819735.
So YH, Choi YH, Oh S, et al. Thrombosed native hemodialysis fistulas: technical and clinical outcomes of endovascular recanalization and factors influencing patency. J Vasc Access. 2019;20:725–32. https://doi.org/10.1177/1129729819848931.
Yilmazsoy Y, Ozyer U. Long-term results of endovascular treatment for arteriovenous dialysis access thrombosis in 143 patients: a single center experience. J Vasc Access. 2019;20:545–52. https://doi.org/10.1177/1129729819865808.
Leo CCH, Cassorla G, Swinnen J. Results of the endovascular treatment system for occluded native arteriovenous fistula. ANZ J Surg. 2020;90:1369–75. https://doi.org/10.1111/ans.16121.
Tan RY, Pang SC, Teh SP, et al. Outcomes of endovascular salvage of clotted arteriovenous access and predictors of patency after thrombectomy. J Vasc Surg. 2020;71:1333–9. https://doi.org/10.1016/j.jvs.2019.07.056.
Lundstrom UH, Welander G, Carrero JJ, et al. Surgical versus endovascular intervention for vascular access thrombosis: a nationwide observational cohort study. Nephrol Dial Transplant. 2022;37:1742–50.
Comments (0)